Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients-Reference-Cited by-同舟云学术

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

Published:2006-04 Issue:4 Volume:17 Page:668-675
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

de las Peñas R.,Sanchez-Ronco M.,Alberola V.,Taron M.,Camps C.,Garcia-Carbonero R.,Massuti B.,Queralt C.,Botia M.,Garcia-Gomez R.,Isla D.,Cobo M.,Santarpia M.,Cecere F.,Mendez P.,Sanchez J.J.,Rosell R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/4/668/13134272/mdj135.pdf

Reference32 articles.

1. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

2. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data;Hoang;J Clin Oncol,2005

3. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects;Matullo;Carcinogenesis,2001

4. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes;Qiao;Carcinogenesis,2002

5. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer;Popanda;Carcinogenesis,2004

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Contribution of DNA Ligase 4 Genetic Variations to Taiwanese Lung Cancer;Anticancer Research;2023-07-26

2. Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancer;Investigational New Drugs;2021-11-18

3. Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients;Archives of Medical Science;2021-02-26

4. Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis;BioMed Research International;2020-10-22

5. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy;Radiology and Oncology;2019-03-28